UK SACT Board annual conference – 28 November 2023

DON’T FORGET TO REGISTER!

UK SACT Board annual conference – 28 November 2023

The UK Systemic Anti-Cancer Therapy (SACT) Board will be hosting its Annual Conference at the Pullman London St Pancras Hotel on Tuesday 28 November 2023. Chaired by Dr Tom Roques, Chair of the UK SACT Board and Vice President, Clinical Oncology at The Royal College of Radiologists, this year’s event will include sessions on SACT capacity in the UK, innovation in SACT practice, a forward look to the next decade in cancer care and digital supportive care.

Registration is just £25 (including VAT). Click here to book your place (booking closes 2 days before the conference) or for more information, please visit the UKSB website.

We look forward to seeing you at what will surely be an exciting, educational and informative day.

Latest News

By BOPA Committee on 29th May 2025

What happens at BOPA’s ITC Course? Hana (@pharmadrama) feeds back!

Hana (@Pharmadrama attends the ITC course) – Access the post here Instagram I went to the @bopacommittee “Introduction to Cancer” 2-day workshop and here’s a video of what happened 😊…

Read article
By BOPA Committee on behalf of UK SACT board on 23rd May 2025

UK SACT Board publication: Guidance on the contents of a SACT protocol

  Dear Colleague,   Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications.   This document has been developed to support…

Read article
By BOPA Executive Committee on 21st May 2025

Vision and Common Purpose for UK Pharmacy Professional Leadership – UKPPL Board and BOPA

BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals.  Through the Board’s work, closer…

Read article
By BOPA Executive Committee on 14th May 2025

BOPA Fellowship Nominations are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025.  There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article